NCT02761993View on ClinicalTrials.gov

Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Periodontal Disease
Interventions
BIOLOGICAL

ST266

1X ST266 applied in a dose of 20 microliters per tooth. Total daily dose will be less than 1 milliliter. ST266 will be applied directly to the marginal gingiva around each tooth (buccal and lingual).

DRUG

Saline (0.9% NaCl)

Saline applied in a dose of 20 microliters per tooth. Total daily dose will be less than 1 milliliter. Saline will be applied directly to the marginal gingiva around each tooth (buccal and lingual).

Trial Locations (6)

10032

Columbia University College of Dental Medicine, New York

27599

University of North Carolina at Chapel Hill School of Dentistry, Chapel Hill

35294

University of Alabama at Birmingham School of Dentistry, Birmingham

46202

Oral Health Research Institute, Indianapolis

02142

Forsyth Institute, Cambridge

11794-8703

Stony Brook School of Dental Medicine, Stony Brook

Sponsors
All Listed Sponsors
lead

Noveome Biotherapeutics, formerly Stemnion

INDUSTRY

NCT02761993 - Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis | Biotech Hunter | Biotech Hunter